Management of Hypertensive Urgency
Hypertensive urgency (BP ≥180/120 mmHg without acute target organ damage) should be managed in the outpatient setting with oral antihypertensive medications, avoiding rapid or aggressive BP reduction that could compromise organ perfusion. 1, 2
Key Distinction from Hypertensive Emergency
Hypertensive urgency differs fundamentally from hypertensive emergency by the absence of acute target organ damage—no evidence of hypertensive encephalopathy, acute stroke, acute MI, acute heart failure with pulmonary edema, aortic dissection, acute renal failure, or retinopathy with hemorrhages/papilledema. 1 This distinction is critical because it determines whether the patient requires immediate hospitalization with IV therapy versus outpatient management.
Initial Assessment and Confirmation
Confirm the BP elevation after a period of rest in a quiet room with multiple measurements, as many patients with acutely elevated BP in emergency settings will normalize when pain or distress is addressed. 1, 3
Rule out acute target organ damage through focused history and examination looking for: chest pain, dyspnea, neurological deficits, visual disturbances, or altered mental status. 1, 4
Identify precipitating factors including medication nonadherence (present in 15.5% of cases), emotional stress (44.8%), acute pain (33.7%), and sympathomimetic drug use (methamphetamine, cocaine). 2, 5
Treatment Approach
Setting and Urgency
Patients with hypertensive urgency do NOT require hospital admission and can be safely managed in the ambulatory setting. 1, 2 The 2024 ESC Guidelines explicitly state that "these patients do not usually require admission to hospital, and BP reduction is best achieved with oral medication." 1
Blood Pressure Reduction Goals
Avoid rapid BP reduction—this is a critical pitfall. Rapid lowering can compromise organ perfusion, especially in elderly patients with altered autoregulatory mechanisms. 6, 3, 4
Short-term goal (days): Progressively lower BP to <160/100 mmHg. 3
Long-term goal: Achieve BP <140/90 mmHg over weeks to months. 3
Target at least a 20% reduction from baseline values initially, but avoid sudden drops. 6
Medication Selection
Use long-acting oral antihypertensive medications—NOT short-acting agents or IV therapy. 2, 6 The evidence shows that:
Oral antihypertensive medications were prescribed in 90.5% of hypertensive urgency cases and effectively reduced BP. 7
Avoid rapid-acting drugs due to the risk of ischemic stroke from precipitous BP drops. 6
Some guidelines recommend starting with combination therapy of two drugs for more effective control. 3
Drug selection should be tailored to comorbidities and contraindications (e.g., beta-blockers in patients with cocaine/methamphetamine use). 1, 3
Common Pitfalls to Avoid
Overly Aggressive Treatment
A major finding from the 2026 ESH-URGEM registry across European centers revealed that 35.1% of hypertensive urgency patients inappropriately received IV therapy, representing overly aggressive management. 5 This practice contradicts guideline recommendations and increases the risk of hypoperfusion.
Discharge BP Targets
Recent evidence challenges the benefit of aggressive BP reduction: A large 2024 study of 12,044 patients found that discharge BP ≤160 mmHg was NOT associated with reduced 30-day major adverse cardiovascular events compared to higher discharge pressures. 8 This supports a conservative approach to BP reduction in the acute setting.
Inadequate Follow-up
Only 24.6% of patients achieved BP <140/90 mmHg at 2-week follow-up in one study, highlighting the importance of close outpatient monitoring. 7
Ensure urgent outpatient follow-up within days to reassess BP control and adjust therapy. 2, 3
Address medication adherence and review precipitating factors at follow-up. 2
Long-term Management Priority
Long-term BP control is paramount to prevent recurrent hypertensive crises and improve overall prognosis, as patients who experience hypertensive urgency have higher cardiovascular risk than those who do not. 6, 4 The one-year major adverse cardiovascular event rate in patients presenting with severe hypertension was 15.5%, emphasizing the importance of sustained BP management. 8